Patents by Inventor Arthur Huang

Arthur Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
    Publication number: 20190185579
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Application
    Filed: July 27, 2018
    Publication date: June 20, 2019
    Inventors: Arthur Huang, Robert Kelley, Henry Lowman, Menno Van Lookeren Campagne, Charles Winter
  • HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
    Publication number: 20180100024
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Application
    Filed: May 18, 2017
    Publication date: April 12, 2018
    Inventors: Arthur HUANG, Robert KELLEY, Henry LOWMAN, Menno VAN LOOKEREN CAMPAGNE, Charles WINTER
  • Humanized anti-factor D antibodies and uses thereof
    Patent number: 9676868
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: June 13, 2017
    Assignee: GENENTECH, INC.
    Inventors: Arthur Huang, Robert Kelley, Henry Lowman, Menno Van Lookeren Campagne, Charles Winter
  • Humanized Anti-Factor D Antibodies And Uses Thereof
    Publication number: 20160145349
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Application
    Filed: November 23, 2015
    Publication date: May 26, 2016
    Inventors: Arthur Huang, Robert Kelley, Henry Lowman, Menno Van Lookeren Campagne, Charles Winter
  • Humanized Anti-Factor D Antibodies And Uses Thereof
    Publication number: 20140212433
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Application
    Filed: March 5, 2014
    Publication date: July 31, 2014
    Applicant: Genentech, Inc.
    Inventors: ARTHUR HUANG, ROBERT KELLEY, HENRY LOWMAN, MENNO VAN LOOKEREN CAMPAGNE, CHARLES WINTER
  • HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
    Publication number: 20140065137
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Application
    Filed: September 20, 2013
    Publication date: March 6, 2014
    Applicant: GENENTECH, INC.
    Inventors: Arthur Huang, Robert Kelley, Henry Lowman, Menno Van Lookeren Campagne, Charles Winter
  • Polynucleotides encoding humanized anti-factor D antibodies
    Patent number: 8614306
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: December 24, 2013
    Assignee: Genentech, Inc.
    Inventors: Arthur Huang, Robert Kelley, Henry Lowman, Menno Van Lookeren Campagne, Charles Winter
  • HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
    Publication number: 20120328613
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Application
    Filed: August 22, 2012
    Publication date: December 27, 2012
    Applicant: GENENTECH, INC.
    Inventors: ARTHUR HUANG, Robert Kelley, Henry Lowman, Menno Van Lookeren Campagne, Charles Winter
  • Humanized anti-factor D antibodies and uses thereof
    Patent number: 8273352
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: September 25, 2012
    Assignee: Genentech, Inc.
    Inventors: Arthur Huang, Robert Kelley, Henry Lowman, Menno Van Lookeren Campagne, Charles Winter
  • HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF
    Publication number: 20090269338
    Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.
    Type: Application
    Filed: April 27, 2009
    Publication date: October 29, 2009
    Applicant: Genentech, Inc.
    Inventors: Arthur Huang, Robert Kelley, Henry Lowman, Menno Van Lookeren Campagne, Charles Winter
  • MONOVALENT ANTIBODY FRAGMENTS USEFUL AS THERAPEUTICS
    Publication number: 20080063641
    Abstract: The invention provides methods and compositions comprising a novel stabilized monovalent antibody fragment.
    Type: Application
    Filed: October 3, 2006
    Publication date: March 13, 2008
    Inventors: Arthur Huang, Ralph Schwall, Daniel Yansura
  • Heteromultimeric molecules
    Publication number: 20060204493
    Abstract: The invention provides heteromultimeric antibodies, and methods of making these antibodies at high yields and purity. The invention also provides methods and compositions for using these antibodies.
    Type: Application
    Filed: September 1, 2005
    Publication date: September 14, 2006
    Inventors: Arthur Huang, Barbara Moffat, Daniel Yansura
  • Monovalent antibody fragments useful as therapeutics
    Publication number: 20050227324
    Abstract: The invention provides methods and compositions comprising a novel stabilized monovalent antibody fragment.
    Type: Application
    Filed: December 17, 2004
    Publication date: October 13, 2005
    Inventors: Arthur Huang, Ralph Schwall, Daniel Yansura
  • System for assigning boot strap processor in symmetric multiprocessor computer with watchdog reassignment
    Patent number: 6009521
    Abstract: A boot strap assignment system is disclosed for a symmetric multiprocessor computer in which the role of the boot strap processor is assigned to one of the working processors by a central agent as part of power-on configuration. The system includes a system management processor which monitors the operation of the multiprocessor computer and controls a switching circuit that selectively transmits the boot strap assignment signal from the central agent to the working processors. Since the management processor monitors environmental conditions and shut-down events, it can predict the failure of working processors and assign the bootstrapping function appropriately. A watch dog timer is also provided in case the bootstrapping fails so that another working processor can be assigned the task of booting up the computer.
    Type: Grant
    Filed: October 23, 1998
    Date of Patent: December 28, 1999
    Assignee: Digital Equipment Corporation
    Inventor: Arthur Huang
  • System for assigning boot strap processor in symmetric multiprocessor computer with watchdog reassignment
    Patent number: 5860002
    Abstract: A boot strap assignment system is disclosed for a symmetric multiprocessor computer in which the role of the boot strap processor is assigned to one of the working processors by a central agent as part of power-on configuration. The system includes a system management processor which monitors the operation of the multiprocessor computer and controls a switching circuit that selectively transmits the boot strap assignment signal from the central agent to the working processors. Since the management processor monitors environmental conditions and shut-down events, it can predict the failure of working processors and assign the bootstrapping function appropriately. A watch dog timer is also provided in case the bootstrapping fails so that another working processor can be assigned the task of booting up the computer.
    Type: Grant
    Filed: July 12, 1996
    Date of Patent: January 12, 1999
    Assignee: Digital Equipment Corporation
    Inventor: Arthur Huang